Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Kelly Banas"'
Publikováno v:
Molecular Therapy: Oncolytics, Vol 11, Iss , Pp 75-89 (2018)
Recent studies point to the evolution of drug resistance in lung cancer as being centered, at least in part, on the upregulation of various genes involved in controlling efflux or drug inactivation. Among the most important of these genes is Nuclear
Externí odkaz:
https://doaj.org/article/b08f67e4d39b4cea9416503519598f39
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0169350 (2017)
CRISPR/Cas9 and single-stranded DNA oligonucleotides (ssODNs) have been used to direct the repair of a single base mutation in human genes. Here, we examine a method designed to increase the precision of RNA guided genome editing in human cells by ut
Externí odkaz:
https://doaj.org/article/d05a9e9964e243fc8fc758f9d43231a1
Figure S1. Fluorescence compensation of mock transfected, GFP- and ATTO 550-fluorescing cells. Figure S2. Representative images used for time course analysis. Figure S3. In vitro cleavage reaction of wildtype and R34G-mutated NRF2 amplicons with vary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63b3da7d77a5cb7115e48adbf58b0236
https://doi.org/10.1158/1541-7786.22513666.v1
https://doi.org/10.1158/1541-7786.22513666.v1
Autor:
Kevin Bloh, Zugui Zhang, Eric B. Kmiec, Pawel Bialk, Rohan Kanchana, Kelly Banas, Byung-Chun Yoo
Publikováno v:
The CRISPR Journal
During CRISPR-directed gene editing, multiple gene repair mechanisms interact to produce a wide and largely unpredictable variety of sequence changes across an edited population of cells. Shortcomings inherent to previously available proposal-based i
Publikováno v:
Leuk Lymphoma
Clustered regularly interspaced palindromic repeats (CRISPR) with the associated (Cas) nuclease complexes have democratized genetic engineering through their precision and ease-of-use. We have applied a variation of this technology, known as CRISPR-d
Publikováno v:
Mol Cancer Res
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)–directed gene editing is approaching clinical implementation in cancer. Thus, it is imperative to define the molecular framework upon which safe and efficacious therapeutic strategi
Autor:
Kelly Banas, Shirin Modarai, Natalia Rivera-Torres, Byung-Chun Yoo, Pawel A. Bialk, Connor Barrett, Mona Batish, Eric B. Kmiec
Publikováno v:
Gene therapy. 29(6)
We have been developing CRISPR-directed gene editing as an augmentative therapy for the treatment of non-small cell lung carcinoma (NSCLC) by genetic disruption of Nuclear Factor Erythroid 2-Related Factor 2 (NRF2). NRF2 promotes tumor cell survival
Recent data suggest that a time lag exists between nuclear penetration and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-directed gene editing activity in human cells. As CRISPR/Cas approaches clinical implementation, it is criti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2d32a02f0323c9613e40ab3c426212c
https://doi.org/10.1101/799676
https://doi.org/10.1101/799676
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0169350 (2017)
PLoS ONE
PLoS ONE
CRISPR/Cas9 and single-stranded DNA oligonucleotides (ssODNs) have been used to direct the repair of a single base mutation in human genes. Here, we examine a method designed to increase the precision of RNA guided genome editing in human cells by ut